Conversely, ACE2 deletion disrupted the benefits of ACE inhibition on diabetic nephropathy in streptozotocin-induced diabetes [65] suggesting that ACE inhibition may enhance ACE2 activity. The gene discussed is ACE2; the disease is diabetes mellitus.